Get the Stockscreener App
1.195
6.19%
0.065
After Hours:
1.21
0.015
+1.26%
Humacyte Inc stock is traded at $1.195, with a volume of 3.88M.
It is up +6.19% in the last 24 hours and down -30.23% over the past month.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
See More
Previous Close:
$1.13
Open:
$1.12
24h Volume:
3.88M
Relative Volume:
0.77
Market Cap:
$211.62M
Revenue:
-
Net Income/Loss:
$-110.78M
P/E Ratio:
-1.1168
EPS:
-1.07
Net Cash Flow:
$-75.59M
1W Performance:
-6.25%
1M Performance:
-30.23%
6M Performance:
-46.43%
1Y Performance:
-73.00%
1-Day Range:
$1.12
$1.21
1-Week Range:
$1.115
$1.43
52-Week Range:
$1.115
$6.77
Humacyte Inc Stock (HUMA) Company Profile
Name
Humacyte Inc
Sector
Industry
Phone
919-313-9633
Address
2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM
Compare HUMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUMA
Humacyte Inc
|
1.195 | 211.62M | 0 | -110.78M | -75.59M | -1.07 |
|
ARGX
Argen X Se Adr
|
918.60 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
435.51 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
201.62 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
363.80 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
725.87 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Humacyte Inc Stock (HUMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-25 | Initiated | Barclays | Overweight |
| May-14-25 | Resumed | H.C. Wainwright | Buy |
| Dec-20-24 | Reiterated | H.C. Wainwright | Buy |
| Dec-11-23 | Initiated | H.C. Wainwright | Buy |
| Aug-14-23 | Upgrade | Piper Sandler | Underweight → Neutral |
| Jun-22-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-16-22 | Downgrade | Piper Sandler | Overweight → Underweight |
| Oct-29-21 | Initiated | Cowen | Outperform |
| Sep-24-21 | Initiated | Oppenheimer | Outperform |
| Sep-22-21 | Initiated | BTIG Research | Buy |
| Sep-16-21 | Initiated | Piper Sandler | Overweight |
View All
Humacyte Inc Stock (HUMA) Latest News
Humacyte introduces Symvess at Veith Symposium - Traders Union
Is Humacyte Inc. Equity Warrant stock attractive for growth ETFsMarket Performance Recap & Long-Term Safe Return Strategies - newser.com
Technical analysis overview for Humacyte Inc. Equity Warrant stockJuly 2025 Opening Moves & Detailed Earnings Play Strategies - newser.com
Will Humacyte Inc. see short term momentumVolume Spike & Weekly Watchlist of Top Performers - newser.com
What recovery options are there for Humacyte Inc. Equity WarrantMarket Sentiment Report & Reliable Price Action Trade Plans - newser.com
Multi asset correlation models including Humacyte Inc. Equity WarrantJuly 2025 Movers & Safe Entry Point Identification - newser.com
How to interpret RSI for Humacyte Inc. stockProfit Target & Fast Gain Swing Trade Alerts - newser.com
Earnings visualization tools for Humacyte Inc.Market Rally & Weekly Stock Performance Updates - newser.com
Is Humacyte Inc. Equity Warrant stock ready for a breakout2025 Risk Factors & Fast Gain Stock Tips - newser.com
Quantitative breakdown of Humacyte Inc. recent moveForecast Cut & AI Driven Stock Movement Reports - newser.com
Real time pattern detection on Humacyte Inc. stockJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com
Chart overlay techniques for tracking Humacyte Inc.2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Can Humacyte Inc. stock reach $100 price targetJuly 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com
Key metrics from Humacyte Inc.’s quarterly dataQuarterly Portfolio Summary & AI Powered Market Entry Ideas - newser.com
Should I hold or sell Humacyte Inc. Equity Warrant stock in 2025Chart Signals & Verified Short-Term Plans - newser.com
Will Humacyte Inc. stock attract more institutional investorsLong Setup & Weekly Return Optimization Plans - newser.com
Is Humacyte Inc. stock trading near support levels2025 Price Targets & Reliable Breakout Stock Forecasts - newser.com
What analysts say about Humacyte Inc Equity Warrant stockMarket Breadth Indicators & Outstanding Capital Returns - earlytimes.in
Is Humacyte Inc. stock cheap compared to fundamentalsJuly 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
Should You Invest in Humacyte, Inc. (HUMA) Based on Bullish Wall Street Views? - Yahoo Finance
Is Humacyte Inc. stock supported by strong cash flowsJuly 2025 Sentiment & AI Driven Stock Price Forecasts - newser.com
Benchmark lowers Humacyte stock price target to $11 on delayed revenue - Investing.com Australia
Will Humacyte Inc. stock deliver shareholder valueMarket Sentiment Report & High Accuracy Swing Trade Signals - newser.com
Benchmark Maintains Humacyte (HUMA) Buy Recommendation - Nasdaq
What Analystss Earnings Revisions Mean for Asian Hotels North Limited StockPortfolio Risk Assessment & Free Proven Portfolio Growth Strategies - earlytimes.in
Using RSI to spot recovery in Humacyte Inc. Equity WarrantCPI Data & Fast Moving Trade Plans - newser.com
Humacyte (HUMA): Benchmark Lowers Price Target While Maintaining 'Buy' Rating | HUMA Stock News - GuruFocus
Benchmark lowers Humacyte stock price target to $11 on delayed revenue By Investing.com - Investing.com Nigeria
Humacyte, Inc. (NASDAQ:HUMA) Q3 2025 Earnings Call Transcript - MSN
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium) - The Manila Times
Why Humacyte Inc. stock remains on buy listsJuly 2025 Update & Free Real-Time Market Sentiment Alerts - newser.com
Humacyte Inc Stock (HUMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Humacyte Inc Stock (HUMA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dougan Brady W | Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Dougan Brady W | Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
| Niklason Laura E | President, CEO and Director |
Aug 19 '25 |
Sale |
1.63 |
1,100,000 |
1,793,000 |
591,685 |
| Niklason Laura E | President, CEO and Director |
Aug 18 '25 |
Sale |
1.83 |
549,360 |
1,005,329 |
1,691,685 |
| Niklason Laura E | President, CEO and Director |
Aug 20 '25 |
Sale |
1.58 |
591,685 |
934,862 |
0 |
2.12%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):